McSAF is a French biotech which develops technologies for stable and homogeneous Antibody-Drug Conjugates (5 proprietary technology patents).   ADC revolutionized the oncological environment and are part of the boiling modalities in targeted therapy.

CliniSciences is a European provider of products and services for research and diagnostics. Here we highlight our peptide, protein and antibody Chemical Synthesis service (GMP).

We have developed the most predictive LifeGel 3DCC oncology research models. Unlike 2DCC and organoid systems, which tend to underestimate GR50 values and generate false positives, LifeGel models demonstrate truly physiological drug resistance aligned with drug levels observed in patient serum.

Expert in process development and GMP manufacturing of biologics and bioconjugates